AlphaVax, Inc., 2 Triangle Drive, Research Triangle Park, NC 27709, USA.
J Gen Virol. 2010 Jul;91(Pt 7):1723-7. doi: 10.1099/vir.0.020081-0. Epub 2010 Feb 24.
Alphavirus-based replicon systems are frequently used as preclinical vectors and as antigen discovery tools, and they have recently been assessed in clinical vaccine trials. Typically, alphavirus replicon RNAs are delivered within virus-like replicon particles (VRP) that are produced following transfection of replicon RNA and two helper RNAs into permissive cells in vitro. The non-structural proteins expressed from the replicon RNA amplify the replicon RNA in cis and the helper RNAs in trans, the latter providing the viral structural proteins necessary to package the replicon RNA into VRP. Current helper RNA designs incorporate the alphavirus 26S promoter to direct the transcription of high levels of structural gene mRNAs. We demonstrate here that the 26S promoter is not required on helper RNAs to produce VRP and propose that such promoterless helper RNAs, by design, reduce the probability of generating replication-competent virus that may otherwise result from RNA recombination.
基于甲病毒的复制子系统常被用作临床前载体和抗原发现工具,最近也在临床试验疫苗中进行了评估。通常,甲病毒复制子 RNA 是在病毒样复制子颗粒 (VRP) 内递送的,该颗粒是在将复制子 RNA 和两种辅助 RNA 转染到体外的允许细胞后产生的。来自复制子 RNA 的非结构蛋白在顺式扩增复制子 RNA,而辅助 RNA 在反式扩增,后者提供将复制子 RNA 包装到 VRP 中所需的病毒结构蛋白。目前的辅助 RNA 设计包含甲病毒 26S 启动子,以指导高水平的结构基因 mRNA 的转录。我们在这里证明,辅助 RNA 上不需要 26S 启动子即可产生 VRP,并提出这种无启动子的辅助 RNA 通过设计降低了产生可能由 RNA 重组引起的复制型病毒的可能性。